Angie E. Bartok

1.2k total citations
5 papers, 526 citations indexed

About

Angie E. Bartok is a scholar working on Epidemiology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Angie E. Bartok has authored 5 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 1 paper in Organic Chemistry. Recurrent topics in Angie E. Bartok's work include Tuberculosis Research and Epidemiology (3 papers), Mycobacterium research and diagnosis (3 papers) and HIV/AIDS drug development and treatment (2 papers). Angie E. Bartok is often cited by papers focused on Tuberculosis Research and Epidemiology (3 papers), Mycobacterium research and diagnosis (3 papers) and HIV/AIDS drug development and treatment (2 papers). Angie E. Bartok collaborates with scholars based in United States. Angie E. Bartok's co-authors include John M. Leedom, J. Allen McCutchan, David Feigal, Joseph Nussbaum, Joseph Chiu, Carol A. Kemper, Jeremiah G. Tilles, Philippe Morlat, Manuel Orellana and Benjamin J. Luft and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Infectious Diseases and Journal of General Internal Medicine.

In The Last Decade

Angie E. Bartok

5 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angie E. Bartok United States 5 416 217 189 61 58 5 526
David Feigal United States 3 291 0.7× 120 0.6× 189 1.0× 32 0.5× 57 1.0× 4 386
M. C. Meyohas France 7 318 0.8× 198 0.9× 75 0.4× 53 0.9× 25 0.4× 13 398
Isabelle Durand-Joly France 16 667 1.6× 507 2.3× 67 0.4× 56 0.9× 35 0.6× 27 750
Thanh Lecompte Switzerland 9 285 0.7× 238 1.1× 47 0.2× 37 0.6× 24 0.4× 15 470
F. Biron France 12 168 0.4× 245 1.1× 63 0.3× 52 0.9× 65 1.1× 42 530
Luís Buzón Spain 11 186 0.4× 222 1.0× 46 0.2× 60 1.0× 200 3.4× 41 597
С. А. Рабинович Russia 10 219 0.5× 116 0.5× 17 0.1× 71 1.2× 73 1.3× 29 387
Eliahou Bishburg United States 7 405 1.0× 326 1.5× 28 0.1× 132 2.2× 37 0.6× 8 562
Namiko Yoshihara Japan 12 436 1.0× 138 0.6× 14 0.1× 22 0.4× 33 0.6× 29 691
Wilfredo Talavera United States 12 285 0.7× 210 1.0× 53 0.3× 94 1.5× 16 0.3× 17 434

Countries citing papers authored by Angie E. Bartok

Since Specialization
Citations

This map shows the geographic impact of Angie E. Bartok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angie E. Bartok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angie E. Bartok more than expected).

Fields of papers citing papers by Angie E. Bartok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angie E. Bartok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angie E. Bartok. The network helps show where Angie E. Bartok may publish in the future.

Co-authorship network of co-authors of Angie E. Bartok

This figure shows the co-authorship network connecting the top 25 collaborators of Angie E. Bartok. A scholar is included among the top collaborators of Angie E. Bartok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angie E. Bartok. Angie E. Bartok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Dubé, Michael P., Fred R. Sattler, Francesca J. Torriani, et al.. (1997). A Randomized Evaluation of Ethambutol for Prevention of Relapse and Drug Resistance during Treatment ofMycobacterium aviumComplex Bacteremia with Clarithromycin‐Based Combination Therapy. The Journal of Infectious Diseases. 176(5). 1225–1232. 65 indexed citations
2.
Kemper, Carol A., Diane V. Havlir, Michael P. Dubé, et al.. (1994). The Individual Microbiologic Effect of Three Antimycobacterial Agents, Clofazimine, Ethambutol, and Rifampin, on Mycobacterium avium Complex Bacteremia in Patients with AIDS. The Journal of Infectious Diseases. 170(1). 157–164. 51 indexed citations
3.
Rickman, Leland S., W. Christopher Mathews, S Fullerton, et al.. (1993). Examiner dependence on physical diagnostic tests for the detection of splenomegaly. Journal of General Internal Medicine. 8(2). 69–75. 39 indexed citations
4.
Kemper, Carol A., Tze‐Chiang Meng, Joseph Nussbaum, et al.. (1992). Treatment of Mycobacterium avium Complex Bacteremia in AIDS with a Four-Drug Oral Regimen. Annals of Internal Medicine. 116(6). 466–472. 110 indexed citations
5.
Dannemann, Brian, J. Allen McCutchan, Dennis Israelski, et al.. (1992). Treatment of Toxoplasmic Encephalitis in Patients with AIDS. Annals of Internal Medicine. 116(1). 33–43. 261 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026